Imunon, Inc. announced that it will receive $10million in funding on August 1, 2024. The company will issue common shares and Warrants to purchase common stock and shares of common stock underlying the warrants in the transaction. The company will issue securities pursuant to exemption provided under Regulation D. The transaction includes participation of 4 accredited investors.

Sales Commission is $700000 in the transaction.